Article Details
Retrieved on: 2024-03-19 14:29:47
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article outlines the growth of the Australian biotech industry, featuring companies like Imugene, which is advancing in immunology with trials of its oncolytic virotherapy in combination with Blinatumomab, guided by leaders like Paul A. Hopper.
Article found on: smallcaps.com.au
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here